Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir intensification in HIV reservoirs
NCT00520897Phase 2Completed
- Sponsor
- Canadian Immunodeficiency Research Collaborative
- Start
- Apr 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Canadian Immunodeficiency Research Collaborative. Started Apr 2007; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00520897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520897.